Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria
· Delayed Price · Currency is NGN 3.160
0.00 (0.00%)
At close: May 13, 2025
NGX:NEIMETH Balance Sheet
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2016 - 2020 |
| Cash & Equivalents | 2,147 | 2,429 | 448.37 | 810.49 | 2,025 | Upgrade
|
| Cash & Short-Term Investments | 2,147 | 2,429 | 448.37 | 810.49 | 2,025 | Upgrade
|
| Cash Growth | -11.63% | 441.78% | -44.68% | -59.98% | -23.14% | Upgrade
|
| Accounts Receivable | 1,272 | 757.72 | 1,299 | 1,209 | 1,211 | Upgrade
|
| Receivables | 1,288 | 803.82 | 1,355 | 1,264 | 1,244 | Upgrade
|
| Inventory | 1,868 | 2,065 | 1,719 | 1,732 | 1,464 | Upgrade
|
| Prepaid Expenses | 50.61 | 40.6 | 21.46 | 103.93 | 18.58 | Upgrade
|
| Other Current Assets | 380.92 | 74.64 | 77.99 | 41.39 | 75.36 | Upgrade
|
| Total Current Assets | 5,735 | 5,414 | 3,622 | 3,951 | 4,828 | Upgrade
|
| Property, Plant & Equipment | 4,209 | 3,665 | 2,855 | 2,436 | 1,412 | Upgrade
|
| Other Intangible Assets | 19 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 2,025 | 1,101 | 34.01 | 34.23 | 35.1 | Upgrade
|
| Total Assets | 11,987 | 10,179 | 6,512 | 6,422 | 6,275 | Upgrade
|
| Accounts Payable | 168.62 | 117.5 | 113.09 | 94.65 | 140.32 | Upgrade
|
| Accrued Expenses | 3,990 | 2,197 | 998.55 | 762.98 | 502.24 | Upgrade
|
| Short-Term Debt | 201.99 | 176.35 | - | 913.16 | 13.57 | Upgrade
|
| Current Portion of Long-Term Debt | 4,859 | 3,883 | 2,158 | 1,096 | 1,100 | Upgrade
|
| Current Portion of Leases | 28.79 | 40.64 | - | - | - | Upgrade
|
| Current Income Taxes Payable | 87.23 | 68.82 | 86.77 | 103.92 | 135.73 | Upgrade
|
| Current Unearned Revenue | 316.69 | 406.71 | 119.04 | 76.93 | 76.93 | Upgrade
|
| Other Current Liabilities | 192.61 | 255.2 | 154.51 | 149.7 | 150.96 | Upgrade
|
| Total Current Liabilities | 9,845 | 7,145 | 3,630 | 3,198 | 2,119 | Upgrade
|
| Long-Term Debt | 294.67 | 288.18 | 1,487 | 1,322 | 1,933 | Upgrade
|
| Long-Term Unearned Revenue | 90.02 | 102.51 | 509.21 | 702.17 | 702.17 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 106.23 | 106.23 | 106.23 | 106.23 | 106.23 | Upgrade
|
| Total Liabilities | 10,336 | 7,642 | 5,733 | 5,328 | 4,861 | Upgrade
|
| Common Stock | 2,137 | 2,137 | 949.58 | 949.58 | 949.58 | Upgrade
|
| Additional Paid-In Capital | 2,378 | 2,378 | 8.82 | 27.38 | 104.88 | Upgrade
|
| Retained Earnings | -2,863 | -1,977 | -179.63 | 117 | 359.61 | Upgrade
|
| Shareholders' Equity | 1,652 | 2,537 | 778.77 | 1,094 | 1,414 | Upgrade
|
| Total Liabilities & Equity | 11,987 | 10,179 | 6,512 | 6,422 | 6,275 | Upgrade
|
| Total Debt | 5,385 | 4,388 | 3,645 | 3,331 | 3,046 | Upgrade
|
| Net Cash (Debt) | -3,238 | -1,959 | -3,197 | -2,521 | -1,021 | Upgrade
|
| Net Cash Per Share | -0.76 | -0.46 | -1.68 | -1.33 | -0.54 | Upgrade
|
| Filing Date Shares Outstanding | 4,273 | 4,273 | 1,899 | 1,899 | 1,899 | Upgrade
|
| Total Common Shares Outstanding | 4,273 | 4,273 | 1,899 | 1,899 | 1,899 | Upgrade
|
| Working Capital | -4,110 | -1,732 | -7.53 | 753.78 | 2,708 | Upgrade
|
| Book Value Per Share | 0.39 | 0.59 | 0.41 | 0.58 | 0.74 | Upgrade
|
| Tangible Book Value | 1,633 | 2,537 | 778.77 | 1,094 | 1,414 | Upgrade
|
| Tangible Book Value Per Share | 0.38 | 0.59 | 0.41 | 0.58 | 0.74 | Upgrade
|
| Land | 85.87 | 85.87 | 85.87 | 85.87 | 85.87 | Upgrade
|
| Buildings | 253.44 | 183.63 | 165.75 | 163.68 | 132.24 | Upgrade
|
| Machinery | 1,931 | 1,804 | 1,930 | 1,833 | 1,481 | Upgrade
|
| Construction In Progress | 3,440 | 2,966 | 1,883 | 1,538 | 778.61 | Upgrade
|
Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.